This inventor holds 8 USPTO granted patents and 8 published patent applications and 4 EPO patents. Top assignees: Critical Care Diagnostics, Inc., Cardiac Pacemakers, Inc., True Health IP LLC. Active years: 2014-2022.
Company Filing History:
7 out of 35 
2 out of 4,110 
1 out of 9 Years Active: 2014-2022
Title: Innovator in Cardiology: The Contributions of Robert W. Gerwien
Introduction
Robert W. Gerwien, an inventive force hailing from Newington, Connecticut, has made significant strides in the field of cardiology with an impressive portfolio of eight patents. His innovative methods aim to improve patient outcomes in the treatment and management of cardiovascular diseases.
Latest Patents
Gerwien's latest work includes groundbreaking methods for treating or predicting the risk of a ventricular tachyarrhythmia (VTA) event. His comprehensive approach involves determining levels of soluble ST2 in biological samples, which can help in selecting and managing cardiac devices such as implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-D). Additionally, he has developed methods for evaluating the risk of a VTA event, thereby offering new insights into patient stratification for clinical studies. Another pivotal area of Gerwien's research focuses on cardiovascular diseases, where he has devised methods for selecting effective therapies and predicting the benefits of exercise therapy based on soluble ST2 levels in patients.
Career Highlights
Throughout his career, Gerwien has worked with notable companies such as Critical Care Diagnostics, Inc. and Cardiac Pacemakers, Inc. His experience in these organizations has paved the way for his groundbreaking patents, positioning him as a vital contributor to advancements in cardiac healthcare.
Collaborations
Gerwien has collaborated with fellow innovators including James V. Snider and Sven Jacobson. These partnerships have enriched his research and enhanced the impact of his patented methods in the field of cardiology.
Conclusion
Robert W. Gerwien’s contributions to medical innovation resonate through his extensive patent portfolio and collaborative efforts. His dedication to improving cardiovascular health through inventive methodologies exemplifies the essence of innovation in modern medicine. As he continues to push the boundaries of cardiac treatment, Gerwien remains a pivotal figure in the ongoing evolution of healthcare practices.